Riskpilot← Back to searchSign inGet full accessPOSEIDON KLINIKKEN ApS
APSActiveCVR 36023252Amerikavej 15B, 2.Other human health activities n.e.c. · NACE 8699Est. 20143 employeeswww.poseidon-klinikken.dk
Revenue 2024
DKK 3,1M
+43% vs 2023
EBITDA margin
39.8%
+17% vs 2023
Equity ratio
52.4%
Financial strength
Net profit 2024
DKK 884K
+18% vs 2023
| Revenue | DKK 3,1M | +43% |
| EBITDA | DKK 1,2M | +17% |
| Net profit | DKK 884K | +18% |
| Total assets | DKK 1,8M | -63% |
| Equity | DKK 935K | -52% |
| Employees | 3 | — |
Legal name
POSEIDON KLINIKKEN ApS
CVR number
36023252
Legal form
Anpartsselskab
NACE code
8699 · Other human health activities n.e.c.
Founded
26. juni 2014
Share capital
DKK 50.000
Employees
3 (FTE)
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive virksomhed indenfor hårtransplantation, samt dermed forbundne aktiviteter.
Address
Amerikavej 15B, 2.
Phone
+4570220225
Email
info@poseidon-klinikken.dk
Website
www.poseidon-klinikken.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 880 | 1.660 | 808 | 1.358 | 907 | 918 | 1.362 | 1.116 | 1.605 | 2.144 | 3.066 |
| Staff expenses | -846 | -1.460 | -882 | -1.107 | -799 | -647 | -685 | -766 | -928 | -1.097 | -1.846 |
| EBITDA | 34 | 199 | -73 | 250 | 108 | 271 | 677 | 349 | 677 | 1.047 | 1.221 |
| Depreciation & amort. | -30 | -59 | -64 | -34 | -4 | -0 | -0 | -45 | -78 | -78 | -84 |
| EBIT | 4 | 140 | -137 | 216 | 103 | 271 | 677 | 304 | 600 | 969 | 1.136 |
| Net financials | -0 | -17 | -2 | -2 | -1 | -1 | -18 | -21 | -3 | -4 | -2 |
| Profit before tax | 4 | 123 | -139 | 214 | 102 | 270 | 660 | 283 | 597 | 966 | 1.134 |
| Tax | -1 | 33 | -45 | 62 | 19 | 60 | 145 | 64 | 131 | 218 | 250 |
| Net profit | 5 | 90 | -95 | 153 | 83 | 210 | 514 | 220 | 465 | 747 | 884 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 525 | 759 | 811 | 821 | 1.049 | 1.594 | 3.712 | 1.672 | 3.846 | 4.774 | 1.785 |
| Equity | 55 | 145 | 51 | 204 | 287 | 497 | 1.011 | 1.231 | 1.696 | 1.936 | 935 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 21 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 471 | 613 | 760 | 618 | 763 | 1.076 | 2.701 | 427 | 2.128 | 2.816 | 829 |
| Total debt | 471 | 613 | 760 | 618 | 763 | 1.097 | 2.701 | 427 | 2.128 | 2.816 | 829 |
EBITDA margin
39.8%
This company
15.8%
Market median
+152% vs market
20142024
Equity ratio
52.4%
This company
38.2%
Market median
+37% vs market
20142024
Return on equity
94.6%
This company
18.4%
Market median
+414% vs market
20142024
Net profit margin
28.8%
This company
8.1%
Market median
+256% vs market
20142024
Asset turnover
1.72×
This company
1.12×
Market median
+54% vs market
20142024
Debt / equity
0.91×
This company
0.62×
Market median
+47% vs market
20142024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-06-26 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LP Management | Management | 2014 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
SCSK 5697 ApS | Company | 50.0% | 50.0% | 2014 |
SCSK 5696 ApS | Company | 50.0% | 50.0% | 2014 |
| Individual | 15.0% | 15.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SCSK 5696 ApS
POSEIDON KLINIKKEN ApS Board members of POSEIDON KLINIKKEN ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Priemé | Management | 0 companies |